The Fenway Institute is excited to announce its collaboration with researchers at the Williams Institute at UCLA School of Law and Columbia University on a first-of-its-kind study of the transgender population in the United States. The objective of “TransPop: U.S. Transgender Population Health Survey” is to use population data to create a comprehensive, accurate picture of the issues that transgender Americans face on a daily basis. The researchers also hope to gain new insights into methodology best practices for surveying transgender people.
TransPop is being led by Dr. Ilan H. Meyer, Williams Senior Scholar of Public Policy at the Williams Institute, and will provide researchers and policymakers with unbiased estimates about the demographics, health outcomes and health care needs of the transgender population by relying on a randomly selected sample of the U.S. population.
To date, most of what researchers know about the transgender population comes from studies that do not use random selection methods and may not accurately represent the population, according to Meyer. TransPop researchers hope the data recovered from this study will shine the light on transgender health concerns that were previously underreported and help service providers develop more targeted programs to meet the needs of this population.
In addition to Meyer, TransPop investigators include Dr. Sari Reisner, ScD, Research Scientist at The Fenway Institute and research fellow, department of epidemiology at Harvard T.H. Chan School of Public Health; Jody Herman, scholar of public policy at the Williams Institute; and Dr. Walter Bockting, professor of medical psychology and co-director of the LGBT Health Initiative at Columbia University.
“TransPop is a truly ground-breaking study,” said Dr. Reisner. “For the first time, random sampling is being used to ascertain representative data about the demographics, health, and well-being of the U.S. transgender population. This is an exciting step forward in population-science and epidemiologic methods in transgender research.”
Want to receive email updates about what’s happening at Fenway Health? Sign up here.